A431 cells hyperproduce EGF receptors and possess inactive p53 proteins. It has been suggested that a cyclindependent kinase (CDK) inhibitor p21/WAF1 plays a crucial role in the EGF-induced cell-cycle arrest of A431 cells. Here, we investigated the role of WAF1 gene transcription in the EGF-induced cell-cycle arrest by transfecting the 18-mer antisense oligonucleotide which corresponds to the 5' region of WAF1 gene (AS/WAF1). When A431 cells were treated with EGF, a cascade of responses were observed, including immediate hyperphosphorylation of EGF receptor on tyrosine residues, accumulation of WAF1 mRNA and p21/WAF1 protein, dephosphorylation of RB protein which is a substrate of CDK-cyclin, and cell-cycle arrest. In the presence of AS/ WAF1, EGF induced the tyrosine-phosphorylation of EGF receptor, but WAF1 mRNA was reduced to a half; accumulation of p21/WAF1 protein and its downstream responses were no longer observed; A431 cells grew continuously. Thus, the transfection of antisense eciently prevented A431 cells from the EGF-induced arrest. These observations suggest that p21/WAF1 protein is a major eector molecule of the EGF-mediated cell-cycle arrest of A431 cells.
Introduction
Epidermal growth factor (EGF) induces tyrosine phosphorylation of the EGF receptor, activates the intracellular signal transduction and enhances the transcription of growth-related genes ( Van der Geer et al., 1994) . EGF acts as a potent mitogen to a wide variety of cells both in vivo and in vitro (Carpenter and Cohen, 1990) . However, EGF inhibits the proliferation of squamous carcinoma A431 cells which possess high numbers of EGF receptor (Gill and Lazar, 1981; Barnes, 1982) , despite intracellular signaling responses are observed (Gill et al., 1985) . Extensive analyses using A431 variants with reduced receptor number revealed the threshold number of EGF receptor on the cell surface for cell-cycle arrest (Gamou et al., 1984; Gill et al., 1985; Yamamoto et al., 1986; Hirai et al., 1988 . Also, growth inhibition by EGF was prevented by blocking of EGF receptors with anti-EGF receptor antibody (Ennis et al., 1989; Fan et al., 1994) . Although these observations allowed us to speculate that hyper-phosphorylation by receptor tyrosine kinase results in a growth arrest Gulli et al., 1996) , a target molecule(s) for cell cyclearrest has not been clari®ed for a long time.
Recently, it was demonstrated that p21/WAF1 protein, a potent inhibitor of cyclin-dependent kinase (CDK) is accumulated in EGF-treated A431 cells and subsequently a CDK-cyclin substrate RB protein is dephosphorylated (Fan et al., 1995; Jakus and Yeudall, 1996) . Thus, it was postulated that EGF induces G1-arrest through inhibiting CDK by p21/WAF1. The p21/WAF1 protein is encoded by WAF1 gene (ElDeiry et al., 1993) , which is also known as Cip1, Cdi1 and Sdi1 gene (Gyuris et al., 1993; Harper et al., 1993; Noda et al., 1994) . It is also known that p53 tumor suppressor protein accumulates transiently when cells are exposed to DNA damaging agents such as radiation and alkylating agents (Haner and Oren, 1995) . The p53 protein is a transcription factor that binds to speci®c DNA sequence in the WAF1 gene promoter (El-Deiry et al., 1995) and directly activates its expression (Haner and Oren, 1995) . Thus, p21/ WAF1 protein is proven to be a direct downstream mediator of p53 protein. However, p53 protein is inactive in A431 cells due to the mutation at codon 273 (273His) (Kwok et al., 1994) and therefore WAF1 gene expression and p21/WAF1 protein accumulation in the EGF-treated A431 cells are considered to be through a p53-independent pathway (Michieli et al., 1994) . The details of this alternative pathway remain to be clari®ed, but the EGF receptor-mediated signaling mechanism is no doubt involved in this p53-independent induction of WAF1 gene.
To investigate whether the EGF-induced cell-cycle arrest of A431 cells depends on p21/WAF1 protein, we employed the antisense inhibition of WAF1 gene. The antisense treatment eciently prevented the EGFinduced cell-cycle arrest of A431 cells, suggesting that p21/WAF1 protein is a major eector molecule of the EGF-induced cell-cycle arrest of A431 cells.
Results

Transfection of oligonucleotides into A431 cells
To investigate the role of p21/WAF1 protein in EGFinduced cell-cycle arrest of A431 cells, 18-mer antisense oligonucleotide was transfected by polyamine method. The eciency of oligonucleotide delivery was ®rst examined using¯uorescein isothiocyanate-labeled 18-mer random oligonucleotide (FITC-RON). When FITC-RON was transfected to 2610 5 A431 cells at ®nal concentration of 0.5 mM, FITC-RON was detected initially as vesicles in more than 95% of cells, diused into the cytoplasm after 3 ± 6 h and then gradually faded away (data not shown). Thus, in a majority of transfection experiments, A431 cells were transfected with AS/WAF1 and control oligonucleotides (see Materials and methods) at 6 h-intervals; 6 h prior to, at the time of and 6 h post-EGF addition.
As shown in Figure 1a , EGF induced a tyrosine phosphorylation of the EGF receptor within 5 min. Even though EGF was removed after 3 h-treatment, the EGF receptor tyrosine phosphorylation kept for subsequent 12 h. AS/WAF1 did not aect the EGFinduced tyrosine phosphorylation of EGF receptor (Figure 1b ).
Antisense inhibition of WAF1 mRNA and p21/WAF1 accumulation Both WAF1 mRNA and p21/WAF1 protein were accumulated in A431 cells 3 h and 6 h after EGF addition, respectively (Figure 2 and 3a) . Following this, cyclin D accumulation, RB protein dephosphorylation as well as cyclin A depletion were observed in the EGF-treated cells (Figure 3a ). The level of cyclin E, p16 and p27/Kip1 was not altered after EGF addition (Figure 3b ). This con®rms previous observations (Fan et al., 1995; Jakus and Yeudall, 1996) and suggests that EGF-induced p21/WAF1 proteins inhibit CDKs and thus downstream response is no longer proceeded. When A431 cells were transfected with AS/WAF1 three times at 6 h-intervals and treated with EGF, WAF1 mRNA was reduced to a half of the mock transfection control (Figure 4a ) and p21/WAF1 protein was barely detected (Figure 4b ). AS/WAF1 transfection also inhibited cyclin D accumulation and RB protein dephosphorylation in EGF-treated cells (Figure 4b ). Transfection with MS/WAF1 and SC/WAF1 (see Materials and methods) did not aect the EGFinduced accumulation of WAF1 mRNA and p21/ WAF1 protein, indicating the antisense eect is sequence-speci®c (data not shown).
Thus, AS/WAF1 transfection inhibited the EGFinduced accumulation of p21/WAF1 protein and kept CDKs and their downstream molecules in active state.
Prevention of EGF-induced growth arrest by antisense
As is well known, EGF treatment inhibited the growth of A431 cells (Figure 5a ). However, transfection with AS/WAF1 three times allowed A431 cells to grow continuously regardless of EGF treatment (Figure 5a ). Transfection with MS/WAF1 or SC/WAF1 was ineective in preventing the EGF-induced cell-cycle arrest. Furthermore, AS/WAF1 transfection was less eective if it was performed after EGF addition (0 and 6 h) (Figure 5b ). AS/WAF1 transfection after WAF1 mRNA accumulation (6 and 12 h and 12 and 18 h) was not eective in preventing the cell-cycle arrest (Figure 5b ). AS/WAF1 transfection without EGF treatment did not aect the growth of A431 cells.
The cell-cycle analysis by FACS con®rmed that EGF induces G1 phase arrest of A431 cells and it is prevented by AS/WAF1 (Figure 5c ). The percentage of A431 cells at G1 phase signi®cantly increased after EGF treatment (44% vs 89%), whereas AS/WAF1 treatment kept the G1 phase cell fraction at the control level (44% vs 51%).
Taken together, AS/WAF1 treatment inhibited WAF1 mRNA and p21/WAF1 protein accumulation, kept CDK(s) in active state and ®nally prevented EGFinduced cell-cycle arrest. Especially, AS/WAF1 which was present prior to the EGF stimulation eciently prevented the EGF-induced cell-cycle arrest of A431. This suggests that newly synthesized p21/WAF1 protein after EGF exposure is essential for the cellcycle arrest of A431. This also rules out the possibility that other cell-cycle regulatory mechanisms may be involved in the EGF-induced cell-cycle arrest in A431 cells.
Discussion
Previously we employed the antisense oligonucleotide expression system to inhibit the EGF receptor gene expression (Hunts et al., 1986; Yamada et al., 1989) . Here, we used the polyamine transfection of antisense oligonucleotide to the 5' region of WAF1 gene. AS/ WAF1 transfection inhibited the p21/WAF1 protein accumulation, its downstream responses and the EGFinduced cell-cycle arrest. Previous observations (Fan et al., 1995; Jakus and Yeudall, 1996) suggested that p21/ WAF1 protein is involved in the EGF-induced cellcycle arrest in A431 cells, although it did not rule out the possibility of the involvement of other cell-cycle regulatory factors. Our results strongly suggest that newly synthesized p21/WAF1 protein after EGF exposure is a major eector molecule of the EGFinduced cell-cycle arrest of A431 and other cell-cycle regulatory elements do not play important roles in this phenomenon.
EGF-induced cell-cycle arrest is observed not only in A431 cells but also in other EGF receptor-hyperproducing cells . Our preliminary study revealed that the p21/WAF1 protein is accumulated after EGF treatment and AS/WAF1 transfection prevents the EGF-induced cell-cycle arrest of NA cells, another EGF receptor-hyperproducing cell line whose growth is inhibited by EGF . Thus, the induction of p21/WAF1 protein seems to be commonly involved in the EGF-induced cell-cycle arrest of EGF receptor-hyperproducing cell lines.
WAF1 gene expression is regulated apparently under two distinct mechanisms. One is the p53-dependent mechanism which is activated by DNA damage (Haner and Oren, 1995) . The other is the p53-independent mechanism that is activated by mitogenic growth factors (Michieli et al., 1994) . The p53-independent mechanism of WAF1 gene induction has been reported using embryonic ®broblasts from p53 knock-out mice (Michieli et al., 1994) in which EGF Figure 4 Eect of AS/WAF1 transfection. A431 cells were treated with EGF for 3 h and the oligonucleotides were transfected at 6 h prior to, at the time of and 6 h post-EGF addition. (a) RNA was extracted 12 h after EGF addition and the Northern blot analysis was carried out using a PCR ampli®ed fragment of WAF1 cDNA as a probe. (b) Cells were lysed 12 h after EGF addition and then subjected to the immunoblot analysis using anti-p21/WAF1 antibody. Cells were lysed 24 h after EGF addition and then subjected to the immunoblot analysis using antibodies against cyclin D and RB protein and other growth factors induce WAF1 gene expression, but DNA damage elicited by gamma-irradiation does not. The p53-independent induction of WAF1 gene is also observed when cells are exposed to oxidative stress (Russo et al., 1995) . Interestingly, hydrogen peroxide as a potent oxidant strongly enhances the tyrosine phosphorylation of EGF receptor (Gamou and Shimizu, 1995) . Thus, excess stimulation of EGF receptor by EGF and oxidant stress induces p21/WAF1 protein accumulation through p53-independent mechanism even in the presence of wild-type p53. Michieli et al. (1994) suggested the distinct role of these two mechanisms: in the human glioma cell line that contains an inactive mutant p53 and an inducible exogenous wild-type p53, p53-independent-transient induction of the p21/WAF1 protein is associated with active proliferation, while p53-dependent induction of the p21/WAF1 protein leads to growth arrest. In addition, we demonstrated the concurrent inhibition of RB protein dephosphorylation by antisense transfection, although it remains to be elucidated whether RB protein plays an essential role in the EGF-induced cell-cycle arrest. Thus, it will be interesting to examine whether WAF1 gene (c) A431 cells were transfected with AS/WAF1 three times and treated with EGF as described. After 48 h incubation, cells were detached with trypsinization, ®xed with ethanol, incubated with RNaseA, and stained with propidium iodide. Cell-cycle analysis was performed using a FACS440. The percentage of each cell-cycle fraction was determined by Barlogie's graphical method expression and subsequent G1-arrest by EGF is induced in cells which possess wild-type p53 protein but dysfunctional RB protein.
EGF activates several signaling mechanisms in A431 cells including MAP kinase and JAK/STAT cascade ( Van der Geer et al., 1994) . Russo et al. (1995) suggested the involvement of MAP kinase cascade in oxidant stress-induced/p53-independent induction of WAF1 gene expression. Pumiglia and Decker (1997) reported that NGF induced cell-growth arrest is mediated by the MAP kinase cascade in the NGF receptor (TrkA)-overexpressing NIH3T3 cells. When A431 cells are exposed to EGF, MAP kinase kinase is tyrosine-phosphorylated by MAP kinase, is translocated into nuclei and regulates the transcription (Van der Geer et al., 1994) . On the other hand, Chin et al. (1996) suggested that EGF-dependent induction of WAF1 gene expression involves JAK/STAT cascade. The STAT1a/p91, a member of STAT family is tyrosine-phosphorylated and transported into nuclei in EGF-treated A431 cells (Fu and Zhang, 1993) . The promoter region of WAF1 gene contains the conserved STAT-responsive element which is speci®cally recognized by activated STAT proteins (Chin et al., 1996) . Since AS/WAF1 did not aect the EGF-induced tyrosine phosphorylation of EGF receptor, the receptor kinase continues to activate the signaling cascade to regulate the WAF1 gene transcription. Thus, MAP kinase and STAT1a/p91 may be tyrosinephosphorylated and translocated into nuclei in the AS/WAF1-and EGF-treated cells. It will be necessary to perform the deletion analysis of WAF1 gene promoter region in order to clarify which cis-element is required for EGF-dependent induction. The use of decoy and antisense oligonucleotides to the STATresponsive element of WAF1 gene promoter region may provide further information of the p53-independent/EGF-dependent mechanism of WAF1 gene expression.
Materials and methods
Cell culture
The human squamous carcinoma A431 cells were cultured in Dulbecco's modi®ed Eagle's medium (DMEM) supplemented with 10% fetal calf serum (FCS) with 5% CO 2 and 100% humidity Gamou and Shimizu, 1995) .
Oligonucleotides and transfection
Oligonucleotides of 18-mer used were as follows: AS/ WAF1, which is an antisense oligonucleotide that targets the 5' region of human WAF1 gene (5'-AGCCGGTTCT-GACATGGC-3'); MS/WAF1, which is an oligonucleotide that contained four bases substitution (5'-AGTC-GATTCTGGCACGGC-3'); SC/WAF1, which had the same base composition as AS/WAF1 but scrambled nucleotide sequence (5'-ACGCGTTGACTGCCTAGG-3'); FITC-RON, which is a¯uorescein isothiocyanate-labeled 18-mer random oligonucleotide.
Oligonucleotide transfection were performed by polyamine method using TransIT-LT1 (Mirus Corp., Madison, WI). Oligonucleotide (5 mM) in 0.1 ml Opti-MEM (GIBCO-BRL, Grand Island, NY) were mixed with TransIT-LT1 (3 ml in 0.1 ml Opti-MEM) 15 min before use. A431 cells in 35 mm dish (approximately 2610 5 cells/dish) were washed with serum-free Opti-MEM, incubated in 0.8 ml of serum-free Opti-MEM with or without EGF (62.5 ng/ml, ultra-pure grade, Toyobo Co., Osaka, Japan) and then added with 0.2 ml of a mixture of oligonucleotide and TransIT-LT1 (®nal volume of medium was 1 ml, ®nal concentration of oligonucleotides and EGF were 0.5 mM and 50 ng/ml, respectively). The medium was replaced to fresh DMEM containing with FCS after 3 h EGF and oligonucleotide treatment. In a majority of experiments, oligonucleotide transfection was repeated three times; 6 h prior to, at the time of and 6 h post-EGF addition.
Immunoblotting and immunostaining
A431 cells were added with EGF and incubated for indicated times as described above. Then, cells were lysed with Laemmli's SDS sample buer. The lysates were electrophoresed on a SDS-polyacrylamide gel and transferred to a PVDF membrane (Immobilon-P, Millipore Co., Bedford, MA). After incubation in non-fat skim milk (3%) for 20 min, immunostaining analysis was carried out using speci®c antibodies. The rabbit antibodies against p16, p27/ Kip1, cyclin A, cyclin E and RB proteins were obtained from Santa Cruz Biotech. (Santa Cruz, CA). The mouse monoclonal antibody against p21/WAF1 protein (clone #70) was obtained from Transduction Lab. (Lexington, KY). The rabbit antibody against cyclin D was obtained from Upstate Biotech. Inc. (Lake Placid, NY). To detect the EGF receptor tyrosine phosphorylation, cells were lysed with Tris-buered saline containing 1% Triton X100. Then, the EGF receptor was immunoprecipitated with mouse monoclonal anti-EGF receptor antibody B4G7 (Behzadian and Shimizu, 1985) and stained with mouse monoclonal anti-phosphotyrosine antibody (4G10, Upstate Biotech. Inc.) (Gamou and Shimizu, 1995) or with mouse monoclonal anti-EGF receptor antibody 29.1 (Sigma, St. Louis, MO).
Northern blotting
Total RNA was extracted by the acid guanidinium-phenolchloroform method. RNA (20 mg) was separated by 1.0% agarose-formalin gel electrophoresis and transferred to a nylon membrane (Byodyn B, Pall BioSupport, East Hills, NY). The hybridization was carried out at 428C in a hybridize solution (50% formamide, 56SSC, 50 mM sodium phosphate, pH 6.9, 46Denhardt's solution and 40 mg/ml ssDNA). A 503 base pairs-fragment of 5' region of human WAF1 cDNA was ampli®ed from A431 cells' RNA by RT±PCR using a pair of primers: GCCGCCATGTCAGAACCGGCTGGGGATGTC and TTAGGGCTTCCTCTTGGAGAAGAT. The ampli®ed WAF1 cDNA was used as a probe after labeling with [a-32 P]-dCTP by a random-priming.
Cell-cycle analysis by FACS
Cell-cycle analysis was carried out using a FACS440 as described previously . The percentage of each cell-cycle fraction was determined by Barlogie's graphical method (Barlogie et al., 1976) .
